Table 2.
Patients’ disease and treatment characteristics
| Characteristic | No. of patients (%) n = 119 |
|---|---|
| Median age, years (range) | 60 (19-84) |
| Sex | |
| Male | 88 (73.9) |
| Female | 31 (26.1) |
| ECOG performance status | |
| 0 | 80 (67.2) |
| 1 | 35 (29.4) |
| 2 | 4 (3.4) |
| Charlson comorbidity index (age-adjusted) | |
| < 4 | 53 (44.5) |
| 4-7 | 61 (51.3) |
| ≥ 8 | 5 (4.2) |
| Smoking history (pack/years) | |
| 0 | 19 (21.2) |
| < 10 | 15 (16.6) |
| 10-20 | 11 (12.2) |
| > 20 | 45 (50.0) |
| Primary tumor | |
| Oropharynx | 68 (57.1) |
| Larynx | 19 (15.8) |
| Hypopharynx | 10 (8.5) |
| Nasopharynx | 22 (18.6) |
| HPV status (oropharynx only) | |
| Positive | 32 (47.0) |
| Negative | 22 (32.4) |
| Unknown | 14 (20.6) |
| T stage at diagnosis (VIIth ed) | |
| 1 | 11 (9.3) |
| 2 | 36 (30.2) |
| 3 | 31 (26.0) |
| 4a/4b | 41 (34.5) |
| N stage at diagnosis (VIIth ed) | |
| 0 | 26 (21.9) |
| 1 | 19 (16.0) |
| 2a/2b/2c | 73 (61.4) |
| 3 | 1 (0.7) |
| AJCC stage at diagnosis (VIIth ed) | |
| I-II | 10 (8.4) |
| III | 27 (22.7) |
| IVA | 76 (63.9) |
| IVB | 6 (5.0) |
| Primary treatment modality | |
| RT | 14 (11.8) |
| Induction CT + RT | 2 (1.7) |
| Induction CT + RCT | 23 (19.3) |
| Induction CT + BRT | 2 (1.7) |
| CRT | 65 (54.6) |
| BRT | 13 (10.9) |